CN Patent

CN121319053A — 一类带有二乙烯基磷酰基的2-氨基嘧啶类化合物及其应用

Assigned to Institute Of Basic Medicine And Oncology Chinese Academy Of Sciences Preparatory · Expires 2026-01-13 · 0y expired

What this patent protects

本发明公开了一类带有二乙烯基磷酰基的2‑氨基嘧啶类化合物及其应用。具体地，本发明公开了一种如式(I)所示的化合物、其立体异构体、互变异构体、晶型、药学上可接受的盐、水合物、溶剂合物或前药。本发明的化合物是一种EGFR抑制剂，可以用于制备治疗和/或预防与EGFR相关的疾病的药物。

USPTO Abstract

本发明公开了一类带有二乙烯基磷酰基的2‑氨基嘧啶类化合物及其应用。具体地，本发明公开了一种如式(I)所示的化合物、其立体异构体、互变异构体、晶型、药学上可接受的盐、水合物、溶剂合物或前药。本发明的化合物是一种EGFR抑制剂，可以用于制备治疗和/或预防与EGFR相关的疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN121319053A
Jurisdiction
CN
Classification
—
Expires
2026-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Institute Of Basic Medicine And Oncology Chinese Academy Of Sciences Preparatory
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.